Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 75,810 shares at $41.14 ($3.1M) on 2019-01-10, disclosed to the SEC on 2019-01-14.
Open-market sale of $3.1M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.47 | 20,880 | $845K | 27.3% |
| 2 | $40.47 | 20,880 | $845K | 27.3% |
| 3 | $41.14 | 34,050 | $1.4M | 45.3% |
| Total | $40.77 avg | 75,810 | $3.1M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |